Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 49-54

  Carey, Amanda N ^a,d   Liu, Xiaoxu ^b   Mintzopoulos, Dionyssios ^b   Paris, Jason J ^c   Muschamp, John W ^b   McLaughlin, Jay P ^a,c   Kaufman, Marc J ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^d SIMMONS COLLEGE   (United States)

Author keywords

HIV 1; Magnetic resonance imaging; NeuroAIDS; Tat; Voxel based morphometry

Indexed keywords

DOXYCYCLINE; TRANSACTIVATOR PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN DISEASE; CONDITIONAL TAT PROTEIN EXPRESSION; CONTROLLED STUDY; ENTORHINAL CORTEX; EX VIVO STUDY; GENE; GENE ACTIVITY; GENE INDUCTION; GRAY MATTER; GRAY MATTER DENSITY ABNORMALITY; GT TG BIGENIC MOUSE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PYRIFORM CORTEX; TAT GENE; VOXEL BASED MORPHOMETRY;

AIDS DEMENTIA COMPLEX; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; DOXYCYCLINE; GENE PRODUCTS, TAT; GLIAL FIBRILLARY ACIDIC PROTEIN; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; TETRACYCLINE;

EID: 84872314217     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.12.018     Document Type: Article

References (60)

1. Aggleton J.P., Albasser M.M., Aggleton D.J., Poirier G.L., Pearce J.M. Lesions of the rat perirhinal cortex spare the acquisition of a complex configural visual discrimination yet impair object recognition. Behav Neurosci 2010, 124:55-68.
2. Aksenov M., Hasselrot U., Bansal A., Wu G., Nath A., Anderson C., et al. Oxidative damage induced by the injection of HIV Tat protein in the rat striatum. Neurosci Lett 2001, 305:5-8.
3. Aksenov M.Y., Hasselrot U., Wu G., Nath A., Anderson C., Mactutus C.F., et al. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 2003, 987:1-9.
4. Aksenova M.V., Aksenov M.Y., Mactutus C.F., Booze R.M. Cell culture models of oxidative stress and injury in the central nervous system. Curr Neurovasc Res 2005, 2:73-89.
5. Anthony I.C., Bell J.E. The neuropathology of HIV/AIDS. Int Rev Psychiatry 2008, 20:15-24.
6. Askenov M.Y., Aksenova M.V., Nath A., Ray P.D., Mactutus C.F., Booze R.M. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 receptor. Neurotoxicology 2006, 27:217-228.
7. Banks W.A., Robinson S.M., Nath A. Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol 2005, 193:218-227.
8. Becker J.T., Maruca V., Kingsley L.A., Sanders J.M., Alger J.R., Barker P.B., et al. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2012, 54:113-121.
9. Behnisch T., Francesconi W., Sanna P.P. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Res 2004, 1012:187-189.
10. Bing E.G., Burnam M.A., Longshore D., Fleishman J.A., Sherbourne C.D., London A.S., et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001, 58:721-728.
11. Bokhari S.M., Yao H., Bethel-Brown C., Fuwang P., Williams R., Dhillon N.K., et al. Morphine enhances Tat-induced activation in murine microglia. J Neurovirol 2009, 15:219-228.
12. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999, 13:1-22.
13. Bruce-Keller A.J., Barger S.W., Moss N.I., Pham J.T., Keller J.N., Nath A. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J Neurochem 2001, 78:1315-1324.
14. Bruce-Keller A.J., Turchan-Cholewo J., Smart E.J., Geurin T., Chauhan A., Reid R., et al. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 2008, 56:1414-1427.
15. Cannistraro P.A., Rauch S.L. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 2003, 37:8-25.
16. Carey A.N., Sypek E.I., Singh H.D., Kaufman M.J., McLaughlin J.P. Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res 2012, 229:48-56.
17. Chen J., Kelz M.B., Zeng G., Sakai N., Steffen C., Shockett P.E., et al. Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol 1998, 54:495-503.
18. Clark J.P., Sampair C.S., Kofuji P., Nath A., Ding J.M. HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol 2005, 289:R656-R662.
19. Conover W.J. Practical nonparametric statistics 1999, John Wiley & Sons, New York. 3rd edition.
20. Cyr M., Caron M.G., Johnson G.A., Laakso A. Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction. Neuroimage 2005, 26:83-90.
21. Everall I., Luthert P., Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993, 52:561-566.
22. Fitting S., Xu R., Bull C., Buch S.K., El-Hage N., Nath A., et al. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 2010, 177:1397-1410.
23. Frankel A.D., Young J.A. HIV fifteen proteins and an RNA. Annu Rev Biochem 1998, 67:1-25.
24. Gavrilovici C., D'Alfonso S., Poulter M.O. Diverse interneuron populations have highly specific interconnectivity in the rat piriform cortex. J Comp Neurol 2010, 518:1570-1588.
25. Glass J.D., Wesselingh S.L., Selnes O.A., McArthur J.C. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993, 43:2230-2237.
26. Griffin W.C., Middaugh L.D., Cook J.E., Tyor W.R. The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function. J Neurovirol 2004, 10:109-115.
27. Johnston J.B., Zhang K., Silva C., Shalinsky D.R., Conant K., Ni W., et al. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 2001, 49:230-241.
28. Kesner R.P., Churchwell J.C. An analysis of rat prefrontal cortex in mediating executive function. Neurobiol Learn Mem 2011, 96:417-431.
29. Kim B.O., Liu Y., Ruan Y., Xu Z.C., Schantz L., He J.J. Neuropathologies in transgenic mice expressing HIV-1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 2003, 162:1693-1707.
30. King J.E., Eugenin E.A., Buckner C.M., Berman J.W. HIV tat and neurotoxicity. Microbes Infect 2006, 8:1347-1357.
31. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lubbert H., et al. Doxycycline mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 1996, 93:10933-10938.
32. Kopnisky K.L., Bao J., Lin Y.W. Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain Behav Immun 2007, 21:428-441.
33. Kraft A.D., Harry G.J. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 2011, 8:2980-3018.
34. Lall G.S., Atkinson L.A., Corlett S.A., Broadbridge P.J., Bonsall D.R. Circadian entrainment and its role in depression: a mechanistic review. J Neural Transm 2012, 119:1085-1096.
35. Langford D., Baron D., Joy J., Del Valle L., Shack J. Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation. Psychoneuroendocrinology 2011, 36:710-719.
36. Lawson M.A., Kelley K.W., Dantzer R. Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav Immun 2011, 25:1569-1575.
37. Li S.T., Matsushita M., Moriwaki A., Saheki Y., Lu Y.F., Tomizawa K., et al. HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning. Ann Neurol 2004, 55:362-371.
38. Lu S.M., Tremblay M.È., King I.L., Qi J., Reynolds H.M., Marker D.F., et al. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 2011, 6:e23915.
39. Mansuy I.M., Winder D.G., Moallem T.M., Osman M., Mayford M., Hawkins R.D., et al. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 1998, 21:257-265.
40. Marker D.F., Tremblay M.-E., Lu S.-M., Majewska A.K., Gelbard H.A. A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation. J Vis Exp 2010, 19(43). [Sep, pii:2059]. 10.3791/2059.
41. Mishra M., Vertivel S., Siddappa N.B., Ranga U. Clade-specific differences in neurotoxicity of human immunodeficiency Virus-1 B and C Tat of human neurons: Significance of dicysteine C30C31 motif. Ann Neurol 2008, 63:366-376.
42. Murray E.A., Richmond B.J. Role of perirhinal cortex in object perception, memory, and associations. Curr Opin Neurobiol 2001, 11:188-193.
43. Nadel L., Hardt O. Update on memory systems and processes. Neuropsychopharmacology 2011, 36:251-273.
44. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 2010, 90:419-463.
45. Power C., McArthur J.C., Nath A., Wehrly K., Mayne M., Nishio J., et al. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998, 72:9045-9053.
46. Ranga U., Shankarappa R., Siddappa N.B., Ramakrishna L., Nagendran R., Mahalingam M., et al. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004, 78:2586-2590.
47. Rao V.R., Sas A.R., Eugenin E.A., Siddappa N.B., Bimonte-Nelson H., Berman J.W., et al. HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 2008, 28:10010-10016.
48. Rappaport J., Joseph J., Croul S., Alexander G., Del Valle L., Amini S., et al. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 1999, 65:458-465.
49. Sarvey J.M., Burgard E.C., Decker G. Long-term potentiation: studies in the hippocampal slice. J Neurosci Methods 1989, 28:109-124.
50. Sawiak S.J., Wood N.I., Williams G.B., Morton A.J., Carpenter T.A. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis 2009, 33:20-27.
51. Schwarcz R., Witter M.P. Memory impairment in temporal lobe epilepsy: the role of entorhinal lesions. Epilepsy Res 2002, 50:161-177.
52. Sei Y., Arora P.K., Skolnick P., Paul I.A. Spatial learning impairment in a murine model of AIDS. FASEB J 1992, 6:3008-3013.
53. Sui Z., Sniderhan L.F., Schifitto G., Phipps R.P., Gelbard H.A., Dewhurst S., et al. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J Immunol 2007, 178:3226-3236.
54. Teyler T.J. Long-term potentiation and memory. Int J Neurol 1987-88, 21-22:163-171.
55. Toborek M., Lee Y.W., Pu H., Malecki A., Flora G., Garrido R., et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem 2003, 84:169-179.
56. Vigorito M., LaShomb A.L., Chang S.L. Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2007, 2:319-328.
57. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25:181-213.
58. Zhou B.Y., Liu Y., Kim B., Xiao Y., He J.J. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci 2004, 27:296-305.
59. Zink W.E., Anderson E., Boyle J., Hock L., Rodriguez-Sierra J., Xiong H., et al. Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci 2002, 22:2096-2105.
60. Zou W., Kim B.O., Zhou B.Y., Liu Y., Messing A., He J.J. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am J Pathol 2007, 171:1923-1935.